Silverback Therapeutics Overview

Life ScienceCompany

Where is Silverback Therapeutics headquartered?

Silverback Therapeutics is headquartered in Seattle, Washington.

How many employees does Silverback Therapeutics have?

Silverback Therapeutics has 67 employees.

What sector is Silverback Therapeutics in?

Silverback Therapeutics is a life science company.

When was Silverback Therapeutics founded?

Silverback Therapeutics was founded in 2016.

Silverback Therapeutics

Silverback Therapeutics, Inc.

500 Fairview Avenue North Suite 600,
Seattle, Washington 98109
United States,
(206) 456-2900
www.silverbacktx.com

Silverback Therapeutics is a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company's lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. It also focuses on developing SBT6290, a product candidate that is in the preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple-negative breast, head and neck, and non-small cell lung cancers. Silverback Therapeutics was founded in 2016 and is based in Seattle, Washington.



Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.